NFKB1 and neoplasm: The outcomes of carcinoma cell TLR signaling affect inflammatory conditions as well as have tumor cell-intrinsic effects unrelated to inflammation, because TLR activate NF-kB [96, 110, 162] and ERK1/2 MAPK [96] pathways in OSCC cells.